Savant Capital, LLC

SEC CIK: 0001482880
Latest filing: Aug 10, 2026

SEC filings (opens in a new tab)

APLS holding history

Apellis Pharmaceuticals, Inc. in every 13F filed by Savant Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APLS overview All 13F holders of APLS Full Q2 2026 holdings

Shares (Q1 2025): 0; Sold out in Q1 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q2 2024

Holdings of APLS by Savant Capital, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2025	0	$0	0.0%	−31,525−100.0%	Sold out	Holders
Q4 2024	31,525	$1.01M	<0.1%	+9,407+42.5%	Added	Holders
Q3 2024	22,118	$637.9K	<0.1%	+8,520+62.7%	Added	Holders
Q2 2024	13,598	$521.6K	<0.1%	+13,598	New	Holders